ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marc P. Pelletier
Andrew Lee
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pelletier, M. P.
Right arrow Articles by Chiu, R. C.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pelletier, M. P.
Right arrow Articles by Chiu, R. C.-J.

Ann Thorac Surg 1998;65:999-1002
© 1998 The Society of Thoracic Surgeons

Negative Reexploration for Cardiac Postoperative Bleeding: Can It Be Therapeutic?

Marc P. Pelletier, MDaa, Susan Solymoss, MDbb, Andrew Lee, BScaa, Ray C.-J. Chiu, MD, PhDaa

a Division of Cardiothoracic Surgery, The Montreal General Hospital/McGill University, Montreal, Quebec, Canada
b Division of Hematology, The Montreal General Hospital, McGill University, Montreal, Quebec, Canada

Accepted for publication October 22, 1997.

Address reprint requests to Dr Chiu, Division of Cardiothoracic Surgery, The Montreal General Hospital, 1650 Cedar Ave, Rm C9.169, Montreal, Quebec, Canada, H3G 1A4

Background. Reexploration of the mediastinum for bleeding is required in 3% to 7% of patients after cardiac operation, with many proving to have no surgically correctable cause. In spite of a "negative exploration," the bleeding often ceases. We propose the hypothesis that such a negative exploration can be therapeutic by reducing marked fibrinolytic activity in the mediastinal cavity.

Methods. Fibrinolytic activity in shed mediastinal blood was compared with that in the system blood in 5 patients after cardiac operation by measuring fibrinogen, fibrin degradation product, plasminogen activator inhibitor-1, and {alpha}2-antiplasmin levels.

Results. Fibrinolytic activity in mediastinal blood was markedly increased when compared with paired systemic venous blood. This was indicated by the mediastinal blood’s lower fibrinogen levels (0.47 versus 1.91 U/mL; p < 0.001), very high levels of fibrin degradation products (1,350 versus 200 ng/mL; p < 0.05), and higher levels of plasminogen activator inhibitor-1 (55.5 versus 28.1 ng/mL; p < 0.005). Decreased levels of {alpha}2-antiplasmin were also observed in the mediastinum (0.50 versus 0.61 U/mL; p < 0.05).

Conclusions. Our data confirm that fibrinolytic activity can be extremely high in the mediastinum in response to clot formation. This may explain the hemostatic effects of a negative reexploration, where irrigation and the removal of clots may reduce the fibrinolytic process; this may allow the bleeding ends of capillaries and small vessels to thrombose. Decreased levels of {alpha}2-antiplasmin observed suggest that lysine analogs, such as {epsilon}-aminocaproic acid, may have a beneficial role when locally delivered into the mediastinum.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.